Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Jimerson, David C.
Wood, James H.
and
Post, Robert M.
1980.
Neurobiology of Cerebrospinal Fluid 1.
p.
743.
Alarcón, Renato D.
and
Franceschini, José A.
1984.
Hyperparathyroidism and Paranoid Psychosis.
British Journal of Psychiatry,
Vol. 145,
Issue. 5,
p.
477.
Thurling, M.L.
1987.
Primary Hyperparathyroidism in a Schizophrenic Woman*.
The Canadian Journal of Psychiatry,
Vol. 32,
Issue. 9,
p.
785.
Khan, A.
and
Tupling, D.
1990.
A Brief Note on Serum Calcium Levels in Schizophrenics and Controls.
The Canadian Journal of Psychiatry,
Vol. 35,
Issue. 1,
p.
74.
Kanofsky, J. Daniel
and
Sandyk, Reuven
1991.
Magnesium Deficiency in Chronic Schizophrenia.
International Journal of Neuroscience,
Vol. 61,
Issue. 1-2,
p.
87.
Mark, Beth Z.
Shakin Kunkel, Elisabeth J.
Fabi, Mark B.
and
Thompson, Troy L.
1993.
Pimozide Is Effective in Delirium Secondary to Hypercalcemia When Other Neuroleptics Fail.
Psychosomatics,
Vol. 34,
Issue. 5,
p.
446.
Soares-Weiser, Karla
Rathbone, John
and
Soares-Weiser, Karla
2004.
Cochrane Database of Systematic Reviews.
Thomas, David
2007.
The Mineral Depletion of Foods Available to US as A Nation (1940–2002) – A Review of the 6th Edition of McCance and Widdowson.
Nutrition and Health,
Vol. 19,
Issue. 1-2,
p.
21.
Essali, Adib
Deirawan, Hany
Soares-Weiser, Karla
and
Adams, Clive E
2011.
Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
Cochrane Database of Systematic Reviews,
Scorza, Fulvio A.
Albuquerque, Marly de
Arida, Ricardo M.
and
Cysneiros, Roberta Monterazzo
2012.
Serum levels of magnesium in sudden cardiac deaths among people with schizophrenia: hit or miss?.
Arquivos de Neuro-Psiquiatria,
Vol. 70,
Issue. 10,
p.
814.
Sarai, Michael
Tejani, Aaron M
Chan, Alice Hill Wah
Kuo, I Fan
and
Li, Juliana
2013.
Magnesium for alcohol withdrawal.
Cochrane Database of Systematic Reviews,
Ruljancic, Nedjeljka
Mihanovic, Mate
Cepelak, Ivana
and
Bakliza, Ana
2013.
Platelet and serum calcium and magnesium concentration in suicidal and non‐suicidal schizophrenic patients.
Psychiatry and Clinical Neurosciences,
Vol. 67,
Issue. 3,
p.
154.
Ordak, Michal
Matras, Joanna
Muszynska, Elzbieta
Nasierowski, Tadeusz
and
Bujalska-Zadrozny, Magdalena
2017.
Magnesium in schizophrenia.
Pharmacological Reports,
Vol. 69,
Issue. 5,
p.
929.
Essali, Adib
Soares-Weiser, Karla
Bergman, Hanna
and
Adams, Clive E
2018.
Calcium channel blockers for antipsychotic-induced tardive dyskinesia.
Cochrane Database of Systematic Reviews,
Vol. 2018,
Issue. 3,
Tinkov, Alexey A.
Skalnaya, Margarita G.
Simashkova, Natalia V.
Klyushnik, Tatiana P.
Skalnaya, Anastasia A.
Bjørklund, Geir
Notova, Svetlana V.
Kiyaeva, Elena V.
and
Skalny, Anatoly V.
2019.
Association between catatonia and levels of hair and serum trace elements and minerals in autism spectrum disorder.
Biomedicine & Pharmacotherapy,
Vol. 109,
Issue. ,
p.
174.
Baj, Jacek
Forma, Alicja
Sitarz, Elżbieta
Karakuła, Kaja
Flieger, Wojciech
Sitarz, Monika
Grochowski, Cezary
Maciejewski, Ryszard
and
Karakula-Juchnowicz, Hanna
2020.
Beyond the Mind—Serum Trace Element Levels in Schizophrenic Patients: A Systematic Review.
International Journal of Molecular Sciences,
Vol. 21,
Issue. 24,
p.
9566.
Huang, Michael W
Gibson, Roger Carl
Jayaram, Mahesh B
and
Caroff, Stanley N
2022.
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
Cochrane Database of Systematic Reviews,
Vol. 2022,
Issue. 7,
Pradeep, A.S.
Abdul Sattar, S.
Seetharami Reddy, B.
and
Durga Prasada Rao, A.
2023.
Levels of a select group of trace elements in scalp hair of schizophrenics by PIXE.
Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms,
Vol. 534,
Issue. ,
p.
81.
Kumar, Aakash
Mehan, Sidharth
Tiwari, Aarti
Khan, Zuber
Gupta, Ghanshyam Das
Narula, Acharan S.
and
Samant, Rajaram
2024.
Magnesium (Mg2+): Essential Mineral for Neuronal Health: From Cellular Biochemistry to Cognitive Health and Behavior Regulation.
Current Pharmaceutical Design,
Vol. 30,
Issue. 39,
p.
3074.
eLetters
No eLetters have been published for this article.